Condition: Obstructive Sleep Apnea · Down Syndrome · Quality of Life · Sponsor: Children's Health Ireland
The goal of this observational study is to learn about the use of non-invasive ventilation for treatment of obstructive sleep apnoea syndrome in children with Down Syndrome. The main questions it aims to answer are: * What is the impact of non-invasive ventilation on sleep behaviours and quality of life? * What barriers are faced by children and their families in establishing tolerance to non-invasive ventilation? Participants will be asked to complete questionnaires before and after starting treatment. Researchers will compare this data with the results of sleep studies and non-invasive ventilator downloads recorded as part of standard medical care. A sub-group of up to 20 participants will be invited to take part in 45-60 minute interviews exploring expectations, experiences and barriers encountered during non-invasive ventilation therapy.
This description comes directly from the study's public registry record.
Roy G Stone · 0035314282626 · refreshed@olchc.ie
Always discuss trial participation with your own doctor first.
| Trinity College Dublin | Dublin, Ireland | Recruiting |
| Children's Health Ireland | Dublin, Ireland | Recruiting |
| Royal Belfast Hospital for Sick Children | Belfast, United Kingdom | Not Yet Recruiting |
| Birmingham Children's Hospital | Birmingham, United Kingdom | Not Yet Recruiting |
| Royal Hospital for Children & Young People | Edinburgh, United Kingdom | Not Yet Recruiting |
| Southampton Children's Hospital | Southampton, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06030349